A French Multi-centric Atrial Fibrillation Catheter Ablation Survey

NCT ID: NCT01918670

Last Updated: 2013-08-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Study Classification

OBSERVATIONAL

Study Start Date

2010-11-30

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Atrial fibrillation is the most frequent sustained arrhythmia. Catheter ablation is a procedure that is currently used for the treatment of symptomatic atrial fibrillation patients.

We have organized a multi-centric national survey of catheter ablation of atrial fibrillation in order to have a feedback on the type of procedures being performed and the overall results (freedom of atrial fibrillation) over an average follow-up of 18 months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Observation of Outcome After Catheter Ablation of Atrial Fibrillation

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

atrial fibrillation; catheter ablation; relapse; stroke; death

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pasteur

catheter ablation of atrial fibrillation

Intervention Type PROCEDURE

electric pulmonary vein disconnection

Grenoble

catheter ablation of atrial fibrillation

Intervention Type PROCEDURE

electric pulmonary vein disconnection

Nantes

catheter ablation of atrial fibrillation

Intervention Type PROCEDURE

electric pulmonary vein disconnection

Parly

catheter ablation of atrial fibrillation

Intervention Type PROCEDURE

electric pulmonary vein disconnection

Rennes

catheter ablation of atrial fibrillation

Intervention Type PROCEDURE

electric pulmonary vein disconnection

Rouen

catheter ablation of atrial fibrillation

Intervention Type PROCEDURE

electric pulmonary vein disconnection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

catheter ablation of atrial fibrillation

electric pulmonary vein disconnection

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all patients undergoing catheter ablation of atrial fibrillation or left atrial flutter

Exclusion Criteria

* patients undergoing catheter ablation of other types of arrhythmia
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Grenoble

OTHER

Sponsor Role collaborator

Nouvelle Clinique Nantaise, Nantes, France

UNKNOWN

Sponsor Role collaborator

Hôpital Privé de Parly II - Le Chesnay

OTHER

Sponsor Role collaborator

Rennes University Hospital

OTHER

Sponsor Role collaborator

University Hospital, Rouen

OTHER

Sponsor Role collaborator

Clinique Pasteur

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Serge Boveda

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinique Pasteur

Toulouse, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FrenchAFAblationSurvey

Identifier Type: -

Identifier Source: org_study_id